An open-label extension trial to assess the long term sa

Project: Research project

Project Details

Description

An open-label extension trial to assess the long term safety of nintedanib in patients with "Systemic Sclerosis associated Interstitial Lung Disease" (SSc-ILD) SENSCIS-ON
StatusActive
Effective start/end date12/1/1712/1/20

Funding

  • Boehringer-Ingelheim Pharmaceuticals

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.